Powder: -20°C for 3 years | In solvent: -80°C for 1 year
S-23 ((S)-3-(4-chloro-3-fluorophenoxy)-N-(4-cyano-3-(trifluoromethyl)phenyl)-2-hydroxy-2-methylpropanamide) 是口服选择性雄激素受体调节剂(Ki:1.7 nM)。它能够诱导 CV-1 细胞雄激素受体介导的转录激活,提高去势大鼠前列腺、精囊和肛提肌重量。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 185 | 现货 | ||
5 mg | ¥ 398 | 现货 | ||
10 mg | ¥ 663 | 现货 | ||
25 mg | ¥ 1,330 | 现货 | ||
50 mg | ¥ 1,980 | 现货 | ||
100 mg | ¥ 3,230 | 现货 | ||
200 mg | ¥ 4,630 | 现货 | ||
500 mg | ¥ 7,150 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 448 | 现货 |
产品描述 | S-23 ((S)-3-(4-chloro-3-fluorophenoxy)-N-(4-cyano-3-(trifluoromethyl)phenyl)-2-hydroxy-2-methylpropanamide) is an oral selective androgen receptor modulator (SARM) with a Ki of 1.7 nM. S-23 increases prostate, seminal vesicle, and levator ani muscle weights in castrated rats. |
靶点活性 | Androgen receptor:1.7 nM(Ki) |
体外活性 | Administration of 10 nM S-23 induces AR-mediated transcriptional activation in CV-1 cells [2]. |
体内活性 | Administration of S-23 to castrated animals increases the weights of the androgen-dependent organ dose-dependently with the ED50s of S-23 in the prostate and levator ani muscle of 0.43 and 0.079 mg/d, respectively[2]. |
别名 | (S)-3-(4-chloro-3-fluorophenoxy)-N-(4-cyano-3-(trifluoromethyl)phenyl)-2-hydroxy-2-methylpropanamide, S23 |
分子量 | 416.75 |
分子式 | C18H13ClF4N2O3 |
CAS No. | 1010396-29-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 88 mg/mL (211.16 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.3995 mL | 11.9976 mL | 23.9952 mL | 59.988 mL |
5 mM | 0.4799 mL | 2.3995 mL | 4.799 mL | 11.9976 mL | |
10 mM | 0.24 mL | 1.1998 mL | 2.3995 mL | 5.9988 mL | |
20 mM | 0.12 mL | 0.5999 mL | 1.1998 mL | 2.9994 mL | |
50 mM | 0.048 mL | 0.24 mL | 0.4799 mL | 1.1998 mL | |
100 mM | 0.024 mL | 0.12 mL | 0.24 mL | 0.5999 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
S-23 1010396-29-8 Endocrinology/Hormones Androgen Receptor activation levator castrated S 23 ani Inhibitor (S)-3-(4-chloro-3-fluorophenoxy)-N-(4-cyano-3-(trifluoromethyl)phenyl)-2-hydroxy-2-methylpropanamide vesicle cells transcriptional muscle prostate S23 seminal CV-1 inhibit inhibitor